(Q37699221)
Statements
Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity (English)
Stephanie J Mihalik
Bret H Goodpaster
David E Kelley
Donald H Chace
Frederico G S Toledo
28 January 2010